Nanjing Vishee Medical Technology Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000041Q0
CNY
54.96
1.05 (1.95%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
458.39
394.53
457.81
318.92
424.61
374.79
315.32
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
458.39
394.53
457.81
318.92
424.61
374.79
315.32
Raw Material Cost
173.06
149.72
141.87
98.33
117.88
107.31
90.49
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
126.99
137.73
167.89
122.85
139.56
88.94
76.47
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.36
1.33
1.33
0.34
0.23
0.47
0.94
Selling and Distribution Expenses
128.50
133.76
166.53
123.82
110.67
101.43
96.92
Other Expenses
-8.83
-9.35
-11.61
-8.27
-7.94
-5.75
-5.19
Total Expenditure (Excl Depreciation)
341.57
329.04
361.48
262.64
288.94
240.65
212.90
Operating Profit (PBDIT) excl Other Income
116.8
65.5
96.30000000000001
56.3
135.7
134.1
102.4
Other Income
19.14
29.85
37.72
39.73
49.54
24.70
6.32
Operating Profit (PBDIT)
180.25
135.59
174.29
125.00
209.07
175.54
123.80
Interest
1.36
1.33
1.33
0.34
0.23
0.47
0.94
Exceptional Items
4.84
2.42
-0.96
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
285.33
244.81
315.94
220.59
306.73
267.47
224.84
Depreciation
29.29
23.41
21.98
18.82
11.46
8.99
8.06
Profit Before Tax
154.43
113.28
150.01
105.84
197.38
166.08
114.80
Tax
16.36
11.31
13.75
12.01
19.84
22.95
15.91
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
138.07
101.97
136.26
93.83
177.81
143.66
99.72
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
138.07
101.97
136.26
93.83
177.81
143.66
99.72
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
-0.28
-0.52
-0.83
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
138.07
101.97
136.26
93.83
177.54
143.13
98.89
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,693.05
1,627.46
1,626.76
1,528.55
1,533.06
1,406.02
249.25
Earnings per share (EPS)
1.44
1.07
1.42
0.98
1.85
1.5
1.04
Diluted Earnings per share
1.44
1.07
1.42
0.98
1.85
1.5
1.04
Operating Profit Margin (Excl OI)
28.76%
20.87%
25.03%
20.83%
34.87%
37.85%
34.7%
Gross Profit Margin
40.08%
34.65%
37.57%
39.09%
49.19%
46.71%
38.96%
PAT Margin
30.12%
25.85%
29.76%
29.42%
41.88%
38.33%
31.62%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 16.20% vs -13.83% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 35.39% vs -25.17% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 52.41% vs -22.62% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 7.69% vs 0.00% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Nanjing Vishee Medical Technology Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
458.39
0
458.39
Other Operating Income
0.00
0.00
0.00
Total Operating income
458.39
0
458.39
Raw Material Cost
173.06
0
173.06
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
126.99
0
126.99
Power Cost
0
0
0.00
Manufacturing Expenses
1.36
0
1.36
Selling and Distribution Expenses
128.50
0
128.50
Other Expenses
-8.83
0.00
-8.83
Total Expenditure (Excl Depreciation)
341.57
0
341.57
Operating Profit (PBDIT) excl Other Income
116.82
0.00
116.82
Other Income
19.14
0
19.14
Operating Profit (PBDIT)
180.25
0
180.25
Interest
1.36
0
1.36
Exceptional Items
4.84
0
4.84
Gross Profit (PBDT)
285.33
0
285.33
Depreciation
29.29
0
29.29
Profit Before Tax
154.43
0
154.43
Tax
16.36
0
16.36
Provisions and contingencies
0
0
0.00
Profit After Tax
138.07
0
138.07
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
138.07
0
138.07
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
138.07
0
138.07
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,693.05
0
1,693.05
Earnings per share (EPS)
1.44
0
1.44
Diluted Earnings per share
1.44
0
1.44
Operating Profit Margin (Excl OI)
28.76%
0%
0.00
28.76%
Gross Profit Margin
40.08%
0%
0.00
40.08%
PAT Margin
30.12%
0%
0.00
30.12%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 45.84 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 16.20% vs -13.83% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 13.81 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 35.39% vs -25.17% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 16.11 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 52.41% vs -22.62% in Dec 2024

Annual - Interest
Interest 0.14 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 7.69% vs 0.00% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 28.76%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024